Tilray Brands, Inc. (TLRY.TO)
CAD 1.69
(-3.98%)
CAD 1.69
(-3.98%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 348.35 Million USD | -4.79% |
| 2022 | 365.86 Million USD | -31.12% |
| 2021 | 531.15 Million USD | -40.26% |
| 2020 | 889.05 Million USD | 203.55% |
| 2019 | 292.88 Million USD | -17.83% |
| 2018 | 356.43 Million USD | 1521.97% |
| 2017 | 21.97 Million USD | -6.86% |
| 2016 | 23.59 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 287.91 Million USD | -23.66% |
| 2023 FY | 348.35 Million USD | -4.79% |
| 2023 Q4 | 348.35 Million USD | -4.68% |
| 2023 Q3 | 365.46 Million USD | 0.74% |
| 2023 Q2 | 362.76 Million USD | 29.23% |
| 2023 Q1 | 280.71 Million USD | -23.27% |
| 2022 Q4 | 365.86 Million USD | 13.94% |
| 2022 FY | 365.86 Million USD | -31.12% |
| 2022 Q1 | 568.14 Million USD | 6.96% |
| 2022 Q2 | 384.44 Million USD | -32.33% |
| 2022 Q3 | 321.1 Million USD | -16.48% |
| 2021 Q2 | 755.93 Million USD | -8.91% |
| 2021 Q1 | 829.88 Million USD | -6.66% |
| 2021 Q4 | 531.15 Million USD | -16.81% |
| 2021 Q3 | 638.49 Million USD | -15.54% |
| 2021 FY | 531.15 Million USD | -40.26% |
| 2020 Q3 | 707.21 Million USD | 74.76% |
| 2020 Q2 | 404.67 Million USD | 30.83% |
| 2020 Q1 | 309.32 Million USD | 5.61% |
| 2020 FY | 889.05 Million USD | 203.55% |
| 2020 Q4 | 889.05 Million USD | 25.71% |
| 2019 FY | 292.88 Million USD | -17.83% |
| 2019 Q1 | 349.15 Million USD | -2.04% |
| 2019 Q3 | 351.33 Million USD | -5.89% |
| 2019 Q2 | 373.33 Million USD | 6.93% |
| 2019 Q4 | 292.88 Million USD | -16.64% |
| 2018 FY | 356.43 Million USD | 1521.97% |
| 2018 Q4 | 356.43 Million USD | 652.42% |
| 2018 Q3 | 47.37 Million USD | 22.93% |
| 2018 Q2 | 38.53 Million USD | -3.78% |
| 2018 Q1 | 40.05 Million USD | 82.25% |
| 2017 Q3 | 23.55 Million USD | -2.27% |
| 2017 Q4 | 21.97 Million USD | -6.72% |
| 2017 FY | 21.97 Million USD | -6.86% |
| 2017 Q1 | 24.84 Million USD | 5.29% |
| 2017 Q2 | 24.1 Million USD | -2.97% |
| 2016 FY | 23.59 Million USD | 0.0% |
| 2016 Q4 | 23.59 Million USD | 333.25% |
| 2016 Q3 | 5.44 Million USD | 7.5% |
| 2016 Q1 | 5.34 Million USD | 0.0% |
| 2016 Q2 | 5.06 Million USD | -5.19% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 47.57 Million CAD | -632.242% |
| Avicanna Inc. | 95.36 Thousand CAD | -365199.595% |
| Avant Brands Inc. | 1.74 Million CAD | -19909.018% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -219639.232% |
| Crescita Therapeutics Inc. | 815 Thousand CAD | -42643.19% |
| Knight Therapeutics Inc. | 44.01 Million CAD | -691.433% |
| MediPharm Labs Corp. | 69 Thousand CAD | -504765.217% |
| OrganiGram Holdings Inc. | 79 Thousand CAD | -440858.228% |
| Canopy Growth Corporation | 493.29 Million CAD | 29.381% |
| Willow Biosciences Inc. | 594 Thousand CAD | -58545.96% |
| Auxly Cannabis Group Inc. | 81.38 Million CAD | -328.046% |